Earnings

Tenet Healthcare Raises FY2026 Adj EPS Guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 Est; Narrows FY2026 Sales Guidance from $21.900B-$22.500B to $22.050B-$22.450B vs $22.351B Est

Oct 29, 2026 · 06:47 AM ET· updated 1h ago

Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 analyst estimate. Narrows FY2026 sales outlook from $21.900 billion-$22.500 billion to $22.050 billion-$22.450

Why It Matters

Tenet Healthcare says it will make more money per share than expected. The company is also being more careful about sales forecasts, showing confidence in profits.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

THC267.00

-1.50 (-0.56%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.